News

Regeneron Pharmaceuticals announced an expanded agreement with the U.S. Department of Health and Human Services (HHS) to develop new treatments combating the novel coronavirus,…
Read More...

Horses with severe equine asthma struggle to breath, even at rest. This week, the European Commission granted marketing authorization1 to Boehringer Ingelheim for the new Aservo…
Read More...

Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, and Levena Biopharma, a company specialized in developing…
Read More...

Teva Pharmaceutical Industries Ltd. announced positive results from two Phase 2/3 trials evaluating AJOVY (fremanezumab) in patients in Japan. AJOVY is under development in Japan by…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA)…
Read More...

BetterLife Pharma Inc. announced the acquisition of Swiss based Solmic AG with its strong IP portfolio including unique formulation technology for the production of stable micelles…
Read More...

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced a…
Read More...

Avacta Group plc , the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has signed a collaboration and license agreement with AffyXell Therapeutics, the…
Read More...

Catalent and MaSTherCell Global announced that Catalent has agreed to acquire MaSTherCell Global, a company backed by Great Point Partners, SFPI-FPIM, and Orgenesis Inc. for an…
Read More...

Seqirus announced that the U.S. Food and Drug Administration (FDA) has approved AUDENZ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) to help protect individuals six months of age…
Read More...

An antiviral compound discovered at Emory University could potentially be used to treat the new coronavirus associated with the outbreak in China and spreading around the globe. Drug…
Read More...

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing…
Read More...

CNS Pharmaceuticals announced that Anthem Biosciences of Bangalore, India (Anthem) has completed a pilot run of the recrystallization of the Reata Pharmaceuticals, Inc. API (Reata). It…
Read More...

Geneyork Pharmaceutical, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, announced the U.S. launch…
Read More...

WPD Pharmaceuticals Inc., a clinical stage pharmaceutical company, provides this update on the completed acquisition of exclusive sublicenses for two drug candidates from Moleculin…
Read More...

Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) has brought together its development laboratories in one Ravensburg site end of last year. Designed…
Read More...

Johnson & Johnson announced that it is mobilizing resources at its Janssen Pharmaceutical Companies to launch a multi-pronged response to the novel coronavirus (also known as…
Read More...

Sandoz announced that it has successfully completed the acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings…
Read More...

Inovio Pharmaceuticals, Inc. announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development in China of INO-4800, Inovio's vaccine against the…
Read More...

Evotec SE announced that its partner Bayer AG has decided to advance a further programme from the endometriosis multi-target alliance into clinical Phase I development. Evotec will…
Read More...